# A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea

> **NCT02849210** · PHASE1 · COMPLETED · sponsor: **Roxall Medicina España S.A** · enrollment: 47 (actual)

## Conditions studied

- Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** Allergovac depot with Olea europaea pollen extract

## Key facts

- **NCT ID:** NCT02849210
- **Lead sponsor:** Roxall Medicina España S.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-06-02
- **Final completion:** 2017-06-02
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2017-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02849210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02849210, "A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02849210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*